SWOG clinical trial number
SWOG-9061 (EST-2190) (INT-0121)

A Phase III Study of Conventional Adjuvant Chemotherapy versus High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation as Adjuvant Intensification Therapy Following Conventional Adjuvant Chemotherapy in Patients with Stage II and III Breast Cancer at High Risk of Recurrence

Closed
Phase
Published
Abbreviated Title
A Phase III Study of Conventional Adjuvant Chemotherapy versus High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation as Adjuvant Intensification Therapy Following…
Activated
01/15/1992
Closed
08/03/1998

Publication Information Expand/Collapse

2003

Phase III study of conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in patients with stage II and III breast cancer at high risk of recurrence (INT 0121)

M Tallman;R Gray;N Robert;C Osborne;W Vaughan;W Gradishar;T Pisansky;J Fetting;E Paietta;H Lazarus Proc of the American Society of Clinical Oncology 22:6(#19)

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer

MS Tallman;R Gray;NJ Robert;CF LeMaistre;CK Osborne;WP Vaughan;WJ Gradishar;TM Pisansky;J Fetting;E Paietta;HM Lazarus New England Journal of Medicine 349(1):17-26